Curie Capital
Rijksdienst voor Ondernemend Nederland · Venture capital
UncertainLast verified 6 Nov 2026
Dutch venture capital firm investing in seed and Series A rounds of life sciences, biotechnology, pharma, and medical technology startups headquartered in the Netherlands.
0 deals in the last 24 months. Taken from its own website.
Key facts
- Stages
- Seed, Series A
- Sectors
- Biotech & pharma, Medtech, Healthtech
- Eligible countries
- Netherlands
- Provider based in
- Netherlands
- Timing
- Rolling applications
- Focus
- Dutch life sciences startups; biotechnology and pharma; medical technology classes IIb and III; therapeutics and diagnostics
- Does not invest in
- companies outside the Netherlands; over €3.5m previously raised
- How to apply
- Apply route unknown
Recent deals
No deals in our data for the last 24 months.
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
Dit investeringsfonds biedt toegang tot haar uitgebreide netwerk en werkt, wanneer nodig, samen met ervaren mede-investeerders.
https://www.rvo.nl/subsidies-financiering/seed-capital/totaaloverzicht-fondsen/curie-capital-3-bv - Sectors
Bij Curie Capital ligt de focus op biotechnologie, farmaceutische en medische technologiebedrijven
https://www.rvo.nl/subsidies-financiering/seed-capital/totaaloverzicht-fondsen/curie-capital-3-bv - Stages
in de series 'seed' en 'A'
https://www.rvo.nl/subsidies-financiering/seed-capital/totaaloverzicht-fondsen/curie-capital-3-bv
Status history
- 6 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Something wrong or out of date? Report an error.
Work at Rijksdienst voor Ondernemend Nederland? Claim this profile to confirm what you invest in.